Literature DB >> 25829295

Pain characteristics and analgesic treatment in an aged adult population: a 4-week retrospective analysis of advanced cancer patients followed at home.

Sebastiano Mercadante1, Federica Aielli, Francesco Masedu, Marco Valenti, Corrado Ficorella, Giampiero Porzio.   

Abstract

BACKGROUND: Studies of cancer pain management in older people are lacking and more information is needed.
OBJECTIVES: The aim of this study was to assess the possible differences in pain intensity, pain mechanisms, breakthrough pain (BTP) medications and use of opioids between adult cancer patients and older cancer patients.
METHODS: A retrospective review of computerized charts was undertaken for advanced cancer patients in the home-care setting. Pain intensity, pain mechanisms, the presence of BTP, analgesic treatments in the last 4 weeks of life, and frequency of change in opioid or route of administration were measured. Patients were divided into two groups: adults (<65 years, A), and aged (≥65 years, O). Within the latter group, three subgroups were assessed: old (65-74 years, O1), older (75-84 years, O2), and the oldest (≥85 years, O3).
RESULTS: A total of 412 patients were available for analysis. No differences in Karnofsky status and survival in the two age groups were found (p=0.2 and p=0.09, respectively). No differences in pain intensity were observed among age subgroups. The O3 group presented a lower prevalence of BTP in comparison with other groups. Significant changes in opioid doses were reported with an inverse relationship with age (p=0.0001). Opioid switching was less frequently present in the older patients (p<0.005).
CONCLUSION: Careful opioid titration may achieve adequate analgesia in older patients by using lower doses of opioids, with a lower rate of opioid switching. The prevalence of BTP was only shown to be lower in the oldest group (O3).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25829295     DOI: 10.1007/s40266-015-0253-1

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  27 in total

1.  Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender.

Authors:  S Mercadante; A Casuccio; S Pumo; F Fulfaro
Journal:  Support Care Cancer       Date:  2000-03       Impact factor: 3.603

2.  Pain management in frail, community-living elderly patients.

Authors:  F Landi; G Onder; M Cesari; G Gambassi; K Steel; A Russo; F Lattanzio; R Bernabei
Journal:  Arch Intern Med       Date:  2001 Dec 10-24

3.  Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio
Journal:  Eur J Pain       Date:  2006-02       Impact factor: 3.931

Review 4.  Opioids and renal function.

Authors:  Sebastiano Mercadante; Edoardo Arcuri
Journal:  J Pain       Date:  2004-02       Impact factor: 5.820

5.  The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose.

Authors:  Susannah Hall; Rollin M Gallagher; Edward Gracely; Calvin Knowlton; Douglas Wescules
Journal:  Pain Med       Date:  2003-06       Impact factor: 3.750

6.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

Review 7.  Pharmacological management of cancer pain in the elderly.

Authors:  Sebastiano Mercadante; Edoardo Arcuri
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Age, pain intensity, and opioid dose in patients with advanced cancer.

Authors:  A Viganó; E Bruera; M E Suarez-Almazor
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

9.  Opioid needs of terminal care patients: variations with age and primary site.

Authors:  W D Rees
Journal:  Clin Oncol (R Coll Radiol)       Date:  1990-03       Impact factor: 4.126

10.  Prescription patterns of analgesics in the last 3 months of life: a retrospective analysis of 10202 lung cancer patients.

Authors:  W Gao; M Gulliford; I J Higginson
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

View more
  3 in total

1.  Age differences in the last week of life in advanced cancer patients followed at home.

Authors:  Sebastiano Mercadante; Federica Aielli; Francesco Masedu; Marco Valenti; Lucilla Verna; Giampiero Porzio
Journal:  Support Care Cancer       Date:  2015-10-16       Impact factor: 3.603

2.  Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study.

Authors:  Jordi Guitart; María Isabel Vargas; Vicente De Sanctis; Jordi Folch; Rafael Salazar; José Fuentes; Joan Coma; Julia Ferreras; Jordi Moya; Albert Tomás; Pere Estivill; Francisco Rodelas; Antonio Javier Jiménez; Almudena Sanz
Journal:  Drugs R D       Date:  2017-09

3.  Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets.

Authors:  Jordi Guitart; María Isabel Vargas; Vicente De Sanctis; Jordi Folch; Rafael Salazar; José Fuentes; Joan Coma; Julia Ferreras; Jordi Moya; Albert Tomás; Pere Estivill; Francisco Rodelas; Antonio Javier Jiménez; Almudena Sanz
Journal:  Drugs R D       Date:  2019-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.